WES Case Study
Identifying a Clinically Relevant Mitochondrial Variant
Download Our Free Whole Exome Sequencing (WES) Case Study Today!
It takes approx. seven years to diagnose a patient with a rare disease. With NEW CentoXome®, this doesn’t have to be the case.
Through utilizing NEW CentoXome, our enhanced Whole Exome Sequencing (WES), we were able to provide a twenty-year-old female and her family with answers.
Take a look at our Case Study to see how we were able shorten this young rare disease patient's diagnostic odyssey.
How NEW CentoXome Can Help You
Access enhanced coverage across the entire exome, full mitochondrial genome, and nearly 100% coverage of all known clinically relevant genes and variants throughout the genome
Increase diagnostic yield by up to 20% compared to conventional WES
Leverage deeper insights to guide the best patient care possible, thanks of the CENTOGENE Biodatabank